This was the ADR's second consecutive day of losses.

"Rising liver disease cases and biotech innovations are fueling demand for advanced therapies, with personalized medicine and fibrosis-targeting treatments shaping the global market landscape." BOSTON ...

According to a new comprehensive report from The Insight Partners, the global ovarian cancer drugs market is observing ...

According to a new comprehensive report from The Insight Partners, the global pulmonary drug delivery system market is ...

(Reuters) -AstraZeneca said on Tuesday that U.S. regulators have approved its precision drug Datroway to treat a type of lung ...